Scholar Rock Holding buy quelbe60
Start price
29.09.24
/
50%
€7.85
Target price
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Scholar Rock Holding | - |
| iShares Core DAX® | 3.523% |
| iShares Nasdaq 100 | 1.026% |
| iShares Nikkei 225® | -0.063% |
| iShares S&P 500 | 0.557% |
Comments by quelbe60 for this prediction
In the thread Scholar Rock Holding diskutieren
Buy Scholar Rock Holding